The Receptor Tyrosine Kinase AXL is Required at Multiple Steps of the Metastatic Cascade during HER2-positive Breast Cancer Progression

Published: 19 March 2018| Version 1 | DOI: 10.17632/xjwbwrb35k.1
Contributor:
Jean-Francois Côté

Description

Western blots from The Receptor Tyrosine Kinase AXL is Required at Multiple Steps of the Metastatic Cascade during HER2-positive Breast Cancer Progression

Files

Institutions

Institut de recherches cliniques de Montreal

Categories

Western Blot

Licence